On the public citation graph

St. George's Respiratory Questionnaire: MCID

0 signed · 894 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/0197-2456(89)90005-6openalex-snapshot
Measurement of health status
inferredcites →https://doi.org/10.1016/0895-4356(95)00583-8openalex-snapshot
A computer-assisted telephone interview technique for assessment of asthma morbidity and drug use in adult asthma
inferredcites →https://doi.org/10.1016/s0140-6736(03)12459-2openalex-snapshot
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(99)07042-7openalex-snapshot
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial
inferredcites →https://doi.org/10.1016/s0895-4356(03)00115-xopenalex-snapshot
Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction
inferredcites →https://doi.org/10.1016/s0954-6111(06)80166-6openalex-snapshot
The St George's Respiratory Questionnaire
inferredcites →https://doi.org/10.1034/j.1399-3003.1999.13f13.xopenalex-snapshot
Analysis of factors that characterize health impairment in patients with chronic respiratory failure
inferredcites →https://doi.org/10.1034/j.1399-3003.1999.14c18.xopenalex-snapshot
A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma
inferredcites →https://doi.org/10.1042/cs0790017openalex-snapshot
Patients' Perception of Distress Due to Symptoms and Effects of Asthma on Daily Living and an Investigation of Possible Influential Factors
inferredcites →https://doi.org/10.1055/s-2000-9841openalex-snapshot
Impact of Lower Respiratory Tract Infections on Health Status
inferredcites →https://doi.org/10.1056/nejmsa030448openalex-snapshot
Cost Effectiveness of Lung-Volume–Reduction Surgery for Patients with Severe Emphysema
inferredcites →https://doi.org/10.1097/00005650-200110000-00002openalex-snapshot
Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life
inferredcites →https://doi.org/10.1097/01.mlr.0000062554.74615.4copenalex-snapshot
Interpretation of Changes in Health-related Quality of Life
inferredcites →https://doi.org/10.1136/bmj.320.7245.1297openalex-snapshot
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
inferredcites →https://doi.org/10.1136/thorax.56.11.880openalex-snapshot
Health status measurement in chronic obstructive pulmonary disease
inferredcites →https://doi.org/10.1136/thorax.58.12.1027openalex-snapshot
Correlation between annual change in health status and computer tomography derived lung density in subjects with 1-antitrypsin deficiency
inferredcites →https://doi.org/10.1136/thx.2005.041996openalex-snapshot
Raised CRP levels mark metabolic and functional impairment in advanced COPD
inferredcites →https://doi.org/10.1136/thx.51.1.39openalex-snapshot
Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease.
inferredcites →https://doi.org/10.1136/thx.51.1.44openalex-snapshot
Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia.
inferredcites →https://doi.org/10.1136/thx.51.5.520openalex-snapshot
Impact of obstructive airways disease on quality of life in older adults.
inferredcites →https://doi.org/10.1136/thx.52.1.67openalex-snapshot
Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease
inferredcites →https://doi.org/10.1136/thx.54.7.581openalex-snapshot
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
inferredcites →https://doi.org/10.1164/ajrccm.155.4.9105068openalex-snapshot
Quality of Life Changes in COPD Patients Treated With Salmeterol
inferredcites →https://doi.org/10.1164/ajrccm.156.2.9607083openalex-snapshot
Validation of the St. George's Respiratory Questionnaire in Bronchiectasis
inferredcites →https://doi.org/10.1164/ajrccm.157.3.9703055openalex-snapshot
Comparison of Discriminative Properties among Disease-specific Questionnaires for Measuring Health-related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1164/ajrccm.157.5.9709032openalex-snapshot
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1164/ajrccm.163.1.2005009openalex-snapshot
Health Status Deterioration in Patients with Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1164/ajrccm.164.5.2007006openalex-snapshot
Inhaled Formoterol Dry Powder Versus Ipratropium Bromide in Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1164/ajrccm/145.6.1321openalex-snapshot
A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory Questionnaire
inferredcites →https://doi.org/10.1164/rccm.200206-583ocopenalex-snapshot
Analysis of the Factors Related to Mortality in Chronic Obstructive Pulmonary Disease: Role of Exercise Capacity and Health Status
inferredcites →https://doi.org/10.1164/rccm.2112043openalex-snapshot
Health-related Quality of Life and Mortality in Male Patients with Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1183/09031936.02.00063702openalex-snapshot
Interpreting thresholds for a clinically significant change in health status in asthma and COPD
inferredcites →https://doi.org/10.1183/09031936.02.00213202openalex-snapshot
Interpretation of quality of life scores from the St George's Respiratory Questionnaire
inferredcites →https://doi.org/10.1183/09031936.02.00238702openalex-snapshot
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
inferredcites →https://doi.org/10.1183/09031936.02.00269802openalex-snapshot
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
inferredcites →https://doi.org/10.1183/09031936.03.00027003openalex-snapshot
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
inferredcites →https://doi.org/10.1183/09031936.03.00031402openalex-snapshot
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
inferredcites →https://doi.org/10.1183/09031936.05.00078504openalex-snapshot
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression
inferredcites →https://doi.org/10.1183/09031936.93.04020167openalex-snapshot
Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries
inferredcites →https://doi.org/10.1183/09031936.94.07010055openalex-snapshot
Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group
inferredcites →https://doi.org/10.1183/1025448x.00038023openalex-snapshot
Quality of life in patients with chronic obstructive pulmonary disease
inferredcites →https://doi.org/10.1586/14737167.4.5.581openalex-snapshot
The truly remarkable universality of half a standard deviation: confirmation through another look

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4091329openalex-extracted
inferred← citeshttps://doi.org/10.2139/ssrn.4462205openalex-extracted
inferred← citeshttps://doi.org/10.1001/archinternmed.2012.1233openalex-snapshot
A Randomized, Placebo-Controlled Trial of Acupuncture in Patients With Chronic Obstructive Pulmonary Disease (COPD)
inferred← citeshttps://doi.org/10.1001/jama.2013.1937openalex-snapshot
Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis
inferred← citeshttps://doi.org/10.1001/jama.2015.17714openalex-snapshot
Bronchoscopic Lung Volume Reduction in COPD
inferred← citeshttps://doi.org/10.1001/jama.2015.17821openalex-snapshot
Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema
inferred← citeshttps://doi.org/10.1001/jama.2017.4451openalex-snapshot
Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation
inferred← citeshttps://doi.org/10.1002/14651858.cd001001.pub2openalex-snapshot
Lung volume reduction surgery for diffuse emphysema
inferred← citeshttps://doi.org/10.1002/14651858.cd001001.pub3openalex-snapshot
Lung volume reduction surgery for diffuse emphysema
inferred← citeshttps://doi.org/10.1002/14651858.cd001287.pub4openalex-snapshot
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd001287.pub5openalex-snapshot
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd001287.pub6openalex-snapshot
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd002309.pub3openalex-snapshot
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd002309.pub4openalex-snapshot
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd002309.pub5openalex-snapshot
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd002309.pub6openalex-snapshot
Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd002990.pub3openalex-snapshot
Self management for patients with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd002990.pub4openalex-snapshot
Self-management interventions for people with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd002996.pub3openalex-snapshot
Inhaled hyperosmolar agents for bronchiectasis
inferred← citeshttps://doi.org/10.1002/14651858.cd003794.pub4openalex-snapshot
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd005305.pub2openalex-snapshot
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd005305.pub3openalex-snapshot
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd005305.pub4openalex-snapshot
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd006829.pub2openalex-snapshot
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus long-acting beta 2 -agonists for chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd008351.pub2openalex-snapshot
Airway clearance techniques for bronchiectasis
inferred← citeshttps://doi.org/10.1002/14651858.cd008351.pub3openalex-snapshot
Airway clearance techniques for bronchiectasis
inferred← citeshttps://doi.org/10.1002/14651858.cd008532.pub3openalex-snapshot
Combination inhaled steroid and long-acting beta 2 -agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd009157.pub2openalex-snapshot
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd009437openalex-snapshot
Integrated disease management interventions for patients with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd009437.pub2openalex-snapshot
Integrated disease management interventions for patients with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd009437.pub3openalex-snapshot
Integrated disease management interventions for patients with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd010337.pub2openalex-snapshot
Interventions for bronchiectasis: an overview of Cochrane systematic reviews
inferred← citeshttps://doi.org/10.1002/14651858.cd011511.pub2openalex-snapshot
Vitamin D for the management of asthma
inferred← citeshttps://doi.org/10.1002/14651858.cd011511.pub3openalex-snapshot
Vitamin D for the management of asthma
inferred← citeshttps://doi.org/10.1002/14651858.cd011682.pub2openalex-snapshot
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd011711openalex-snapshot
Respiratory muscle training in children and adults with neuromuscular disease
inferred← citeshttps://doi.org/10.1002/14651858.cd011711.pub2openalex-snapshot
Respiratory muscle training in children and adults with neuromuscular disease
inferred← citeshttps://doi.org/10.1002/14651858.cd012158.pub2openalex-snapshot
Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd012290.pub2openalex-snapshot
Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd012528.pub2openalex-snapshot
Self-management for bronchiectasis
inferred← citeshttps://doi.org/10.1002/14651858.cd013110.pub2openalex-snapshot
Exercise training for bronchiectasis
inferred← citeshttps://doi.org/10.1002/14651858.cd013196.pub2openalex-snapshot
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD)
inferred← citeshttps://doi.org/10.1002/14651858.cd013343.pub2openalex-snapshot
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/14651858.cd013381.pub2openalex-snapshot
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD)
inferred← citeshttps://doi.org/10.1002/14651858.cd013384.pub2openalex-snapshot
Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review
inferred← citeshttps://doi.org/10.1002/14651858.cd013485.pub2openalex-snapshot
Pulmonary rehabilitation versus usual care for adults with asthma
inferred← citeshttps://doi.org/10.1002/14651858.cd013569.pub2openalex-snapshot
Supervised maintenance programmes following pulmonary rehabilitation compared to usual care for chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1002/acr2.11125openalex-snapshot
Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II
inferred← citeshttps://doi.org/10.1002/cpt.1540openalex-snapshot
Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives
inferred← citeshttps://doi.org/10.1002/jcsm.12228openalex-snapshot
Targeted medical nutrition for cachexia in chronic obstructive pulmonary disease: a randomized, controlled trial
inferred← citeshttps://doi.org/10.1002/jmri.28940openalex-snapshot
Review of Hyperpolarized Pulmonary Functional 129Xe MR for Long‐COVID
inferred← citeshttps://doi.org/10.1002/jpen.2350openalex-snapshot
Undernutrition is associated with mortality, exacerbation, and poorer quality of life in patients with chronic obstructive pulmonary disease: A systematic review with meta‐analysis of observational studies
inferred← citeshttps://doi.org/10.1002/ppul.22842openalex-snapshot
Increased asthma risk and impaired quality of life after bronchiolitis or pneumonia in infancy
inferred← citeshttps://doi.org/10.1007/978-3-031-17299-1_2841openalex-snapshot
St. George’s Respiratory Questionnaire
inferred← citeshttps://doi.org/10.1007/978-3-0348-0709-8_7openalex-snapshot
Phase III Clinical Efficacy of Indacaterol: Patient-Centered Outcomes
inferred← citeshttps://doi.org/10.1007/978-3-319-61452-6_19openalex-snapshot
Pulmonary Rehabilitation in Bronchiectasis
inferred← citeshttps://doi.org/10.1007/978-3-319-65888-9_19openalex-snapshot
Patient-Centered Outcomes
inferred← citeshttps://doi.org/10.1007/978-981-32-9366-3_18openalex-snapshot
The Use of Ozone as Redox Modulator in the Treatment of the Chronic Obstructive Pulmonary Disease (COPD)
inferred← citeshttps://doi.org/10.1007/s00210-025-04558-1openalex-snapshot
A comprehensive systematic review and meta-analysis of ensifentrine in COPD: dose-dependent effects, safety profile, and GRADE-based certainty of evidence
inferred← citeshttps://doi.org/10.1007/s00408-012-9444-2openalex-snapshot
Safety and Efficacy of 12-Week or Longer Indacaterol Treatment in Moderate-to-Severe COPD Patients: A Systematic Review
inferred← citeshttps://doi.org/10.1007/s00408-016-9969-xopenalex-snapshot
Early Trends in Bronchoscopic Lung Volume Reduction: A Systematic Review and Meta-analysis of Efficacy Parameters
inferred← citeshttps://doi.org/10.1007/s00408-020-00368-9openalex-snapshot
Determining Static Hyperinflation in Patients with Severe Emphysema: Relation Between Lung Function Parameters and Patient-Related Outcomes
inferred← citeshttps://doi.org/10.1007/s00408-024-00777-0openalex-snapshot
Surgical and Bronchoscopic Lung Volume Reduction for Severe Emphysema: A Systematic Review and Network Meta-analysis
inferred← citeshttps://doi.org/10.1007/s00408-025-00803-9openalex-snapshot
Biologics in COPD: Do We Need a Divide and Conquer Approach?
inferred← citeshttps://doi.org/10.1007/s00408-026-00889-9openalex-snapshot
Efficacy and Safety of Inhaled GM-CSF in Autoimmune Pulmonary Alveolar Proteinosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials
inferred← citeshttps://doi.org/10.1007/s00508-008-1066-6openalex-snapshot
Der Effekt von einem Jahr ambulanter pneumologischer Rehabilitation auf Patienten mit COPD
inferred← citeshttps://doi.org/10.1007/s00508-022-02073-4openalex-snapshot
Effect of intravenous ferric carboxymaltose on exercise capacity and quality of life in patients with COPD
inferred← citeshttps://doi.org/10.1007/s00540-026-03735-7openalex-snapshot
Impact of prevention of postoperative pulmonary complications with penehyclidine inhalation on long-term outcomes in high-risk patients: follow-up of a randomized trial
inferred← citeshttps://doi.org/10.1007/s11096-007-9152-9openalex-snapshot
Measuring health-related quality of life in drug clinical trials: is it given due importance?
inferred← citeshttps://doi.org/10.1007/s11136-010-9632-6openalex-snapshot
Effectiveness of a Tai chi Qigong program in promoting health-related quality of life and perceived social support in chronic obstructive pulmonary disease clients
inferred← citeshttps://doi.org/10.1007/s11136-013-0570-yopenalex-snapshot
The St George’s Respiratory Questionnaire revisited: a psychometric evaluation
inferred← citeshttps://doi.org/10.1007/s11655-025-3924-8openalex-snapshot
Traditional Chinese Exercise Improves Lung Function and Exercise Capacity in Patients with Preserved Ratio Impaired Spirometry
inferred← citeshttps://doi.org/10.1007/s11655-025-3943-5openalex-snapshot
Therapeutic Mechanism of Yihuo Huatan Formula in Stable Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial Integrating Metabolomics and 16S rRNA Gene Sequencing
inferred← citeshttps://doi.org/10.1007/s12325-009-0080-zopenalex-snapshot
Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1007/s12325-013-0019-2openalex-snapshot
Aclidinium Bromide Twice Daily for the Treatment of Chronic Obstructive Pulmonary Disease: A Review
inferred← citeshttps://doi.org/10.1007/s12325-016-0430-6openalex-snapshot
Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials
inferred← citeshttps://doi.org/10.1007/s12325-020-01266-5openalex-snapshot
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS
inferred← citeshttps://doi.org/10.1007/s12325-020-01311-3openalex-snapshot
Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
inferred← citeshttps://doi.org/10.1007/s12325-020-01557-xopenalex-snapshot
Effects of Tiotropium/Olodaterol on Activity-Related Breathlessness, Exercise Endurance and Physical Activity in Patients with COPD: Narrative Review with Meta-/Pooled Analyses
inferred← citeshttps://doi.org/10.1007/s12325-022-02231-0openalex-snapshot
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis
inferred← citeshttps://doi.org/10.1007/s12445-017-0313-3openalex-snapshot
De Ziektelastmeter COPD als hulpmiddel in de praktijk
inferred← citeshttps://doi.org/10.1007/s12576-019-00716-2openalex-snapshot
A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1007/s40261-013-0138-1openalex-snapshot
ACCORD COPD II: A Randomized Clinical Trial to Evaluate the 12-Week Efficacy and Safety of Twice-Daily Aclidinium Bromide in Chronic Obstructive Pulmonary Disease Patients
inferred← citeshttps://doi.org/10.1007/s40265-014-0194-8openalex-snapshot
QVA149 (Indacaterol/Glycopyrronium Fixed-Dose Combination): A Review of Its Use in Patients with Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1007/s40268-016-0131-2openalex-snapshot
Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
inferred← citeshttps://doi.org/10.1007/s40271-019-00386-7openalex-snapshot
COPD-Specific Self-Management Support Provided by Trained Educators in Everyday Practice is Associated with Improved Quality of Life, Health-Directed Behaviors, and Skill and Technique Acquisition: A Convergent Embedded Mixed-Methods Study
inferred← citeshttps://doi.org/10.1007/s41030-016-0012-4openalex-snapshot
Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials
inferred← citeshttps://doi.org/10.1007/s41030-017-0048-0openalex-snapshot
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
inferred← citeshttps://doi.org/10.1007/s41030-020-00136-3openalex-snapshot
Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial
inferred← citeshttps://doi.org/10.1007/s41030-026-00354-1openalex-snapshot
Oscillating Positive Expiratory Pressure (OPEP) Therapy in Bronchiectasis and Chronic Obstructive Pulmonary Disease (COPD): A Narrative Review of Clinical Studies
inferred← citeshttps://doi.org/10.1016/b978-3-437-24285-4.00009-4openalex-snapshot
Asthma bronchiale
inferred← citeshttps://doi.org/10.1016/j.acra.2016.08.021openalex-snapshot
Noncystic Fibrosis Bronchiectasis
inferred← citeshttps://doi.org/10.1016/j.alergo.2017.02.007openalex-snapshot
Minimalna różnica istotna klinicznie (MCID) dla zmniejszenia częstości zaostrzeń przewlekłej obturacyjnej choroby płuc – czyli, która terapia jest w rzeczywistości odczuwana przez chorego
inferred← citeshttps://doi.org/10.1016/j.alit.2022.07.004openalex-snapshot
Efficacy and safety of tezepelumab in patients recruited in Japan who participated in the phase 3 NAVIGATOR study
inferred← citeshttps://doi.org/10.1016/j.anai.2024.02.013openalex-snapshot
Assessing meaningful change in the Asthma Impairment and Risk Questionnaire
inferred← citeshttps://doi.org/10.1016/j.apmr.2022.07.019openalex-snapshot
Letter to the editor on “Effectiveness of Continuous Chest Wall Vibration With Concurrent Aerobic Training on Dyspnea and Functional Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial”
inferred← citeshttps://doi.org/10.1016/j.apmr.2022.08.003openalex-snapshot
Response to Letter to the Editor on “Effectiveness of Continuous Chest Wall Vibration With Concurrent Aerobic Training on Dyspnea and Functional Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial”
inferred← citeshttps://doi.org/10.1016/j.athoracsur.2025.07.029openalex-snapshot
Tracheobronchoplasty for Excessive Dynamic Airway Collapse and Tracheobronchomalacia: A Comparative Analysis of Distinct Airway Disorders
inferred← citeshttps://doi.org/10.1016/j.bjpt.2026.101577openalex-snapshot
Effects of pulmonary rehabilitation on the perception of happiness in individuals with COPD: A randomized clinical trial
inferred← citeshttps://doi.org/10.1016/j.ccm.2017.11.013openalex-snapshot
Bronchoscopic Lung Volume Reduction
inferred← citeshttps://doi.org/10.1016/j.ccm.2025.02.011openalex-snapshot
Expiratory Central Airway Collapse
inferred← citeshttps://doi.org/10.1016/j.cct.2023.107203openalex-snapshot
Chronic Obstructive Pulmonary Disease Access and Adherence to Pulmonary Rehabilitation Intervention (CAPRI): Protocol for a randomized controlled trial and adaptations during the COVID-19 pandemic
inferred← citeshttps://doi.org/10.1016/j.chest.2015.11.025openalex-snapshot
Age-Related Differences in Health-Related Quality of Life in COPD
inferred← citeshttps://doi.org/10.1016/j.chest.2016.02.658openalex-snapshot
The Responsiveness of the Anxiety Inventory for Respiratory Disease Scale Following Pulmonary Rehabilitation
inferred← citeshttps://doi.org/10.1016/j.chest.2016.06.011openalex-snapshot
Differences in Health-Related Quality of Life Between New Mexican Hispanic and Non-Hispanic White Smokers
inferred← citeshttps://doi.org/10.1016/j.chest.2016.08.1432openalex-snapshot
Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD
inferred← citeshttps://doi.org/10.1016/j.chest.2017.11.038openalex-snapshot
Asthma Is a Risk Factor for Respiratory Exacerbations Without Increased Rate of Lung Function Decline
inferred← citeshttps://doi.org/10.1016/j.chest.2018.01.053openalex-snapshot
Tai Chi and Pulmonary Rehabilitation Compared for Treatment-Naive Patients With COPD
inferred← citeshttps://doi.org/10.1016/j.chest.2018.11.028openalex-snapshot
Aspirin Use and Respiratory Morbidity in COPD
inferred← citeshttps://doi.org/10.1016/j.chest.2019.02.012openalex-snapshot
Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema
inferred← citeshttps://doi.org/10.1016/j.chest.2020.02.045openalex-snapshot
Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Fatigue in Patients With COPD Following Pulmonary Rehabilitation
inferred← citeshttps://doi.org/10.1016/j.chest.2021.01.004openalex-snapshot
Protein Biomarkers for COPD Outcomes
inferred← citeshttps://doi.org/10.1016/j.chest.2022.02.049openalex-snapshot
Impact of Airline Secondhand Tobacco Smoke Exposure on Respiratory Health and Lung Function Decades After Exposure Cessation
inferred← citeshttps://doi.org/10.1016/j.chest.2023.01.007openalex-snapshot
Safety and Efficacy of Combined Resveratrol and Sirolimus in Lymphangioleiomyomatosis
inferred← citeshttps://doi.org/10.1016/j.chest.2023.11.033openalex-snapshot
Silent Airway Mucus Plugs in COPD and Clinical Implications
inferred← citeshttps://doi.org/10.1016/j.chest.2024.07.183openalex-snapshot
Impact of Dyspnea on Adults With Respiratory Symptoms Without a Defined Diagnosis
inferred← citeshttps://doi.org/10.1016/j.chest.2024.11.007openalex-snapshot
Dietary Pattern, Sputum DNA Methylation, and Lung Health
inferred← citeshttps://doi.org/10.1016/j.chest.2025.06.022openalex-snapshot
Airway Mucus Plugging in Chronic Bronchitis and the Impact of Bronchial Rheoplasty
inferred← citeshttps://doi.org/10.1016/j.chest.2025.10.037openalex-snapshot
Clinical Outcomes in Patients With COPD With Disease Stability
inferred← citeshttps://doi.org/10.1016/j.chpulm.2024.100113openalex-snapshot
High BMI and COPD Outcomes in Alpha-1 Antitrypsin Deficiency
inferred← citeshttps://doi.org/10.1016/j.clinthera.2011.11.009openalex-snapshot
Efficacy and Tolerability of Indacaterol 75 μg Once Daily in Patients Aged ≥40 Years With Chronic Obstructive Pulmonary Disease: Results From 2 Double-Blind, Placebo-Controlled 12-Week Studies
inferred← citeshttps://doi.org/10.1016/j.coi.2025.102720openalex-snapshot
Optimizing patient-reported outcomes for sarcoidosis
inferred← citeshttps://doi.org/10.1016/j.conctc.2022.100931openalex-snapshot
Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1016/j.ctim.2023.102977openalex-snapshot
Tai Chi as a complementary exercise for pulmonary rehabilitation in chronic obstructive pulmonary disease: A randomised controlled trial
inferred← citeshttps://doi.org/10.1016/j.ebiom.2021.103587openalex-snapshot
Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis
inferred← citeshttps://doi.org/10.1016/j.ejcdt.2015.11.006openalex-snapshot
Effect of comorbidities on response to pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1016/j.ejim.2017.05.021openalex-snapshot
Characterization of circadian COPD symptoms by phenotype: Methodology of the STORICO observational study
inferred← citeshttps://doi.org/10.1016/j.envint.2023.108286openalex-snapshot
Randomised controlled trial of a behavioural intervention to reduce exposure to PM2.5 in patients with COPD
inferred← citeshttps://doi.org/10.1016/j.healun.2018.06.005openalex-snapshot
Frailty and clinical benefits with lung transplantation
inferred← citeshttps://doi.org/10.1016/j.healun.2025.09.024openalex-snapshot
Timing of quality of life and lung function changes during the first year following lung transplantation: A multicenter prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e21539openalex-snapshot
Management of COPD and Comorbidities in COPD patients by Dispensing Pharmaceutical Care following Global Initiative for chronic Obstructive Lung Disease-Guidelines (GOLD guidelines 2020): A study protocol for a Prospective Randomized Clinical Trial
inferred← citeshttps://doi.org/10.1016/j.ijcard.2016.10.016openalex-snapshot
What is the impact of impaired left ventricular ejection fraction in COPD after adjusting for confounders?
inferred← citeshttps://doi.org/10.1016/j.ijmedinf.2022.104754openalex-snapshot
Design and delivery of home-based telehealth pulmonary rehabilitation programs in COPD: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ijsu.2020.04.010openalex-snapshot
Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ijtb.2026.07.031openalex-snapshot
Pulmonary rehabilitation and inspiratory muscle training in post-tuberculosis lung disease: A randomized controlled trial assessing functional capacity, respiratory muscle strength, and quality of life
inferred← citeshttps://doi.org/10.1016/j.jaip.2020.08.032openalex-snapshot
Quantification of Glucocorticoid-Associated Morbidity in Severe Asthma Using the Glucocorticoid Toxicity Index
inferred← citeshttps://doi.org/10.1016/j.jaip.2022.05.012openalex-snapshot
Effectiveness of Interventions Targeting Treatable Traits for the Management of Obstructive Airway Diseases: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1016/j.jaip.2023.12.030openalex-snapshot
Ventilation Heterogeneity Is a Treatable Trait in Severe Asthma
inferred← citeshttps://doi.org/10.1016/j.jaip.2024.01.020openalex-snapshot
Treatable Traits in Asthma: The Importance of Extrapulmonary Traits—GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety
inferred← citeshttps://doi.org/10.1016/j.jaip.2024.10.024openalex-snapshot
Longitudinal Assessment of Glucocorticoid Toxicity Reduction in Patients With Severe Asthma Treated With Biologic Therapies
inferred← citeshttps://doi.org/10.1016/j.jamda.2016.05.002openalex-snapshot
Sarcopenia in Advanced COPD Affects Cardiometabolic Risk Reduction by Short-Term High-intensity Pulmonary Rehabilitation
inferred← citeshttps://doi.org/10.1016/j.jamda.2016.08.002openalex-snapshot
Responsiveness and MCID Estimates for CAT, CCQ, and HADS in Patients With COPD Undergoing Pulmonary Rehabilitation: A Prospective Analysis
inferred← citeshttps://doi.org/10.1016/j.jamda.2016.11.016openalex-snapshot
The Impact of Cognitive Impairment on Efficacy of Pulmonary Rehabilitation in Patients With COPD
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2019.07.015openalex-snapshot
Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study
inferred← citeshttps://doi.org/10.1016/j.jdin.2021.09.003openalex-snapshot
Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort study
inferred← citeshttps://doi.org/10.1016/j.jpainsymman.2019.09.007openalex-snapshot
Acupuncture for Breathlessness in Advanced Diseases: A Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jpsychores.2011.10.004openalex-snapshot
Behavioral and characterological self-blame in chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2017.01.019openalex-snapshot
Prevalence, determinants and clinical correlates of vitamin D deficiency in patients with Chronic Obstructive Pulmonary Disease in London, UK
inferred← citeshttps://doi.org/10.1016/j.jsmc.2024.04.008openalex-snapshot
The Role of High Flow Nasal Therapy in Chronic Respiratory Failure
inferred← citeshttps://doi.org/10.1016/j.jtcvs.2018.07.118openalex-snapshot
First series of minimally invasive, robot-assisted tracheobronchoplasty with mesh for severe tracheobronchomalacia
inferred← citeshttps://doi.org/10.1016/j.jtcvs.2021.07.012openalex-snapshot
Robotic-assisted tracheobronchoplasty: Quality of life and pulmonary function assessment on intermediate follow-up
inferred← citeshttps://doi.org/10.1016/j.jtcvs.2022.07.040openalex-snapshot
Improvement in postoperative lung function in patients with moderate to severe airway obstruction after robotic-assisted thoracoscopic tracheobronchoplasty
inferred← citeshttps://doi.org/10.1016/j.jval.2012.01.009openalex-snapshot
Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD: A Patient-Level Mixed Treatment Comparison
inferred← citeshttps://doi.org/10.1016/j.jval.2018.10.008openalex-snapshot
Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine
inferred← citeshttps://doi.org/10.1016/j.kine.2016.06.001openalex-snapshot
Désencombrement bronchique et bronchectasies : de bons indicateurs mais encore un long chemin à parcourir pour comprendre son efficacité et ses effets
inferred← citeshttps://doi.org/10.1016/j.kine.2018.01.009openalex-snapshot
Effets de l’électrostimulation neuromusculaire combinée des triceps suraux et des quadriceps dans la BPCO sévère et très sévère lors d’un programme de réhabilitation respiratoire
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2010.12.008openalex-snapshot
The use of long acting β2-agonists, alone or in combination with inhaled corticosteroids, in Chronic Obstructive Pulmonary Disease (COPD)
inferred← citeshttps://doi.org/10.1016/j.physio.2009.04.007openalex-snapshot
Pulmonary rehabilitation for chronic obstructive pulmonary disease: a pilot study evaluating a once-weekly versus twice-weekly supervised programme
inferred← citeshttps://doi.org/10.1016/j.physio.2014.04.002openalex-snapshot
Differences in patient outcomes between a 6, 7 and 8 week pulmonary rehabilitation programme: A service evaluation
inferred← citeshttps://doi.org/10.1016/j.physio.2019.08.007openalex-snapshot
Minimal important difference for London Chest Activity of Daily Living scale in patients with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1016/j.physio.2026.102386openalex-snapshot
Effects of Chair-Based Exercise Training on Pulmonary Function, Exercise Capacity, and Quality of Life in Patients with Acute Exacerbation of COPD: A Randomised Controlled Trial
inferred← citeshttps://doi.org/10.1016/j.pupt.2007.12.004openalex-snapshot
The impact of inhaled corticosteroid and long-acting β-agonist combination therapy on outcomes in COPD
inferred← citeshttps://doi.org/10.1016/j.pupt.2013.02.006openalex-snapshot
Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity
inferred← citeshttps://doi.org/10.1016/j.pupt.2013.04.004openalex-snapshot
Efficacy and safety of roflumilast in patients with stable chronic obstructive pulmonary disease: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.pupt.2015.02.008openalex-snapshot
The impact of treatment with indacaterol in patients with COPD: A post-hoc analysis according to GOLD 2011 categories A to D
inferred← citeshttps://doi.org/10.1016/j.pupt.2017.04.002openalex-snapshot
Role of dual bronchodilators in COPD: A review of the current evidence for indacaterol/glycopyrronium
inferred← citeshttps://doi.org/10.1016/j.pupt.2017.12.005openalex-snapshot
Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1016/j.rehab.2025.102021openalex-snapshot
Effect of different forms of upper limb muscle training on dyspnea in chronic obstructive pulmonary disease: a randomised controlled trial
inferred← citeshttps://doi.org/10.1016/j.resinv.2021.08.002openalex-snapshot
Treatment efficacy of LAMA versus placebo for stable chronic obstructive pulmonary disease: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.resinv.2023.04.004openalex-snapshot
One-year change in the health status predicts the subsequent hospitalization and mortality in patients waitlisted for lung transplantation in Japan
inferred← citeshttps://doi.org/10.1016/j.resp.2010.06.005openalex-snapshot
Effect of 4 weeks of Acu-TENS on functional capacity and β-endorphin level in subjects with chronic obstructive pulmonary disease: A randomized controlled trial
inferred← citeshttps://doi.org/10.1016/j.rmed.2009.09.006openalex-snapshot
The SF-36 and SGRQ: Validity and first look at minimum important differences in IPF
inferred← citeshttps://doi.org/10.1016/j.rmed.2010.06.004openalex-snapshot
A one-year trial of tiotropium Respimat® plus usual therapy in COPD patients
inferred← citeshttps://doi.org/10.1016/j.rmed.2011.02.013openalex-snapshot
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD
inferred← citeshttps://doi.org/10.1016/j.rmed.2011.07.020openalex-snapshot
Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study
inferred← citeshttps://doi.org/10.1016/j.rmed.2011.08.005openalex-snapshot
A homeopathic remedy for early COPD
inferred← citeshttps://doi.org/10.1016/j.rmed.2011.12.021openalex-snapshot
The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis
inferred← citeshttps://doi.org/10.1016/j.rmed.2012.08.016openalex-snapshot
Short term and long term effects of pulmonary rehabilitation on physical activity in COPD
inferred← citeshttps://doi.org/10.1016/j.rmed.2012.08.022openalex-snapshot
Indacaterol therapy in patients with COPD not receiving other maintenance treatment
inferred← citeshttps://doi.org/10.1016/j.rmed.2012.09.002openalex-snapshot
Assessing efficacy of indacaterol in moderate and severe COPD patients: A 12-week study in an Asian population
inferred← citeshttps://doi.org/10.1016/j.rmed.2012.10.022openalex-snapshot
Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use
inferred← citeshttps://doi.org/10.1016/j.rmed.2013.02.011openalex-snapshot
Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD
inferred← citeshttps://doi.org/10.1016/j.rmed.2013.06.001openalex-snapshot
Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
inferred← citeshttps://doi.org/10.1016/j.rmed.2013.07.001openalex-snapshot
Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD
inferred← citeshttps://doi.org/10.1016/j.rmed.2013.11.003openalex-snapshot
The clinical impact of non-obstructive chronic bronchitis in current and former smokers
inferred← citeshttps://doi.org/10.1016/j.rmed.2013.11.016openalex-snapshot
Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: A prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.rmed.2014.05.011openalex-snapshot
The effect of an outpatient care on-demand-system on health status and costs in patients with COPD. A randomized trial
inferred← citeshttps://doi.org/10.1016/j.rmed.2015.05.012openalex-snapshot
Indacaterol vs tiotropium in COPD patients classified as GOLD A and B
inferred← citeshttps://doi.org/10.1016/j.rmed.2015.06.006openalex-snapshot
Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies
inferred← citeshttps://doi.org/10.1016/j.rmed.2015.09.007openalex-snapshot
Development of chronic pulmonary aspergillosis in adult asthmatics with ABPA
inferred← citeshttps://doi.org/10.1016/j.rmed.2015.10.008openalex-snapshot
Differences in change in coping styles between good responders, moderate responders and non-responders to pulmonary rehabilitation
inferred← citeshttps://doi.org/10.1016/j.rmed.2015.11.008openalex-snapshot
Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence
inferred← citeshttps://doi.org/10.1016/j.rmed.2016.10.002openalex-snapshot
Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses
inferred← citeshttps://doi.org/10.1016/j.rmed.2016.12.001openalex-snapshot
A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 μg versus once-daily vilanterol 25 μg to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD
inferred← citeshttps://doi.org/10.1016/j.rmed.2017.03.015openalex-snapshot
Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1016/j.rmed.2017.03.029openalex-snapshot
Changes in physical activity and sedentary behaviour following pulmonary rehabilitation in patients with COPD
inferred← citeshttps://doi.org/10.1016/j.rmed.2017.04.015openalex-snapshot
Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma
inferred← citeshttps://doi.org/10.1016/j.rmed.2017.08.023openalex-snapshot
Manometry Optimized Positive Expiratory Pressure (MOPEP) in Excessive Dynamic Airway Collapse (EDAC)
inferred← citeshttps://doi.org/10.1016/j.rmed.2019.06.010openalex-snapshot
Extrapulmonary associations of health status in severe asthma and bronchiectasis: Comorbidities and functional outcomes
inferred← citeshttps://doi.org/10.1016/j.rmed.2019.07.019openalex-snapshot
Effect of smoking status on lung function, patient-reported outcomes, and safety among patients with COPD treated with indacaterol/glycopyrrolate: Pooled analysis of the FLIGHT1 and FLIGHT2 studies
showing the first 200 of 852 · page through all 852
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.